Research Institute of Oil Tea Camellia, Hunan Academy of Forestry, Shao Shan South Road, No. 658, Changsha 410004, China.
National Engineering Research Center for Oil Tea Camellia, Changsha 410004, China.
Nutrients. 2022 Jun 10;14(12):2424. doi: 10.3390/nu14122424.
Camellia () seed oil (CO) has been shown to effectively reduce the blood lipid level of its host due to its fatty acid content, but the specific molecular mechanism associated with the metabolic phenotype after digestion is not clear. Here, we further investigated the relationship between branched-chain amino acids (BCAA) and the metabolic phenotype that may exhibit the anti-dyslipidemia effect of CO on mice fed a high-fat diet for 30 day C57BL/6J male mice were allocated to three groups: the control group (Cont), the high-fat feed group (HFD), and a high-fat feed group with CO treatment (CO). A serum sample was collected to detect lipid biomarkers and BCAA concentration. Notably, Low-density lipoprotein (LDL), Total Cholesterol (TC), and Triglycerides (TG) showed a significant decrease, whereas High-density lipoprotein (HDL) increased in CO mice but not in the HFD group. The concentration of Isoleucine (Ile), leucine (Leu), and valine (Val) was similar between the Cont and CO groups compared with the HFD group, exhibiting an inhibition induced by CO in mice fed with a high-fat diet. A metabolic phenotype from serum examined by non-targeted metabolite analysis using UHPLC/MS showed most metabolites exhibited lipid and BCAA metabolism. The results indicated that CO treatment notably regulated the metabolism of arachidonic acid and steroid biosynthesis in response to HFD-induced dyslipidemia. In addition, the expression of PPARγ genes that correlated with the BCAA and serum lipid biomarkers were compared, and significant inhibition was noticed, which might lead to the potential exposure of the anti-dyslipidemia mechanism of CO in HFD-fed mice. In conclusion, the expression of PPARγ genes, serum lipid level, BCAA concentration, and the metabolic phenotype was significantly positive in correlation with a high-fat diet, whereas oral CO improved the biomarkers and metabolism of some specific serum metabolites in HFD-fed mice.
油茶籽油 (CO) 因其脂肪酸含量而被证明能有效降低宿主的血脂水平,但消化后与代谢表型相关的具体分子机制尚不清楚。在这里,我们进一步研究了支链氨基酸 (BCAA) 与代谢表型之间的关系,这种代谢表型可能表现出 CO 对高脂饮食喂养 30 天的 C57BL/6J 雄性小鼠的抗血脂异常作用。将雄性小鼠分为三组:对照组 (Cont)、高脂饲料组 (HFD) 和 CO 处理的高脂饲料组 (CO)。采集血清样本检测脂质生物标志物和 BCAA 浓度。值得注意的是,CO 组小鼠的低密度脂蛋白 (LDL)、总胆固醇 (TC) 和甘油三酯 (TG) 显著降低,而高密度脂蛋白 (HDL) 升高,但 HFD 组小鼠则没有。与 HFD 组相比,Cont 组和 CO 组的异亮氨酸 (Ile)、亮氨酸 (Leu) 和缬氨酸 (Val) 浓度相似,表明 CO 对高脂饮食喂养的小鼠有抑制作用。采用 UHPLC/MS 进行非靶向代谢物分析,对血清进行代谢表型检测,结果显示大多数代谢物表现出脂质和 BCAA 代谢。结果表明,CO 处理显著调节了花生四烯酸和类固醇生物合成代谢,以响应 HFD 诱导的血脂异常。此外,比较了与 BCAA 和血清脂质生物标志物相关的 PPARγ 基因的表达,发现其表达受到显著抑制,这可能导致 CO 在 HFD 喂养小鼠中抗血脂异常机制的潜在暴露。总之,PPARγ 基因的表达、血清脂质水平、BCAA 浓度和代谢表型与高脂肪饮食呈显著正相关,而口服 CO 可改善 HFD 喂养小鼠的一些特定血清代谢物的生物标志物和代谢。